$TMGI
Marquie Group, Inc.

2024 Q1 Form 10-Q Financial Statement

#000168316824000369 Filed on January 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $128.1K $166.8K $183.1K
YoY Change 84.4% -8.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $220.00 $220.00 $780.00
YoY Change -4.35% -71.79%
% of Gross Profit
Operating Expenses $128.1K $166.8K $88.69K
YoY Change 84.41% 88.04% 17.02%
Operating Profit -$128.1K -$166.8K -$88.69K
YoY Change 84.41% 88.04% 17.02%
Interest Expense $128.6K $135.3K $79.92K
YoY Change 25.39% 69.33% -51.64%
% of Operating Profit
Other Income/Expense, Net -$330.8K $32.65K -$79.92K
YoY Change -45.21% -140.85% -105.04%
Pretax Income -$458.9K -$134.1K $1.634M
YoY Change -31.83% -108.21%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$458.9K -$134.1K -$168.6K
YoY Change -31.83% -20.46% -111.16%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 825.6M shares 756.6M shares 16.19M shares
Diluted Shares Outstanding 1.211B shares 427.6M shares 292.9M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.160K $2.430K $780.00
YoY Change 4220.0% 211.54%
Cash & Equivalents $2.162K $2.433K $784.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $882.00 $483.00 $1.389K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.162K $2.433K $784.00
YoY Change 4704.44% 210.33%
LONG-TERM ASSETS
Property, Plant & Equipment $880.00 $480.00 $1.390K
YoY Change -24.14% -65.47%
Goodwill
YoY Change
Intangibles $11.17K $10.37K $10.37K
YoY Change 7.72% 0.0%
Long-Term Investments $6.200M $6.200M $6.200M
YoY Change 0.0% 0.0%
Other Assets $6.247M $6.239M $6.221M
YoY Change 0.2% 0.29%
Total Long-Term Assets $6.247M $6.239M $6.221M
YoY Change 0.2% 0.29%
TOTAL ASSETS
Total Short-Term Assets $2.162K $2.433K $784.00
Total Long-Term Assets $6.247M $6.239M $6.221M
Total Assets $6.249M $6.242M $6.222M
YoY Change 0.23% 0.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $70.66K $70.00K $71.32K
YoY Change 1.79% -1.85%
Accrued Expenses $2.161M $2.010M $1.435M
YoY Change 37.2% 40.05%
Deferred Revenue
YoY Change
Short-Term Debt $3.628M $3.567M $3.470M
YoY Change 3.31% 2.79%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.463M $6.017M $7.809M
YoY Change -3.44% -22.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.463M $6.017M $7.809M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $6.463M $6.017M $7.809M
YoY Change -3.44% -22.95%
SHAREHOLDERS EQUITY
Retained Earnings -$14.94M -$14.48M -$16.16M
YoY Change -0.61% -10.39%
Common Stock $141.1K $115.4K $75.66K
YoY Change 86.46% 52.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$213.5K $224.8K -$1.587M
YoY Change
Total Liabilities & Shareholders Equity $6.249M $6.242M $6.222M
YoY Change 0.23% 0.32%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$458.9K -$134.1K -$168.6K
YoY Change -31.83% -20.46% -111.16%
Depreciation, Depletion And Amortization $220.00 $220.00 $780.00
YoY Change -4.35% -71.79%
Cash From Operating Activities -$71.47K -$106.2K -$47.66K
YoY Change 519.32% 122.81%
INVESTING ACTIVITIES
Capital Expenditures $800.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$7.610K $0.00 -$9.250K
YoY Change -45.64% -100.0%
Cash From Investing Activities -$8.410K $0.00 -$9.250K
YoY Change -39.93% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 79.62K 108.5K 57.34K
YoY Change 221.05% 89.24%
NET CHANGE
Cash From Operating Activities -71.47K -106.2K -47.66K
Cash From Investing Activities -8.410K 0.000 -9.250K
Cash From Financing Activities 79.62K 108.5K 57.34K
Net Change In Cash -260.0 2.320K 430.0
YoY Change -64.86% 439.53%
FREE CASH FLOW
Cash From Operating Activities -$71.47K -$106.2K -$47.66K
Capital Expenditures $800.00
Free Cash Flow -$72.27K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001434601
CY2022Q3 us-gaap Stock Option Down Round Feature Increase Decrease In Equity Amount1
StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount1
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-11-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54163
dei Entity Registrant Name
EntityRegistrantName
The Marquie Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2091212
dei Entity Address Address Line1
EntityAddressAddressLine1
7901 4th St N
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4000
dei Entity Address City Or Town
EntityAddressCityOrTown
St. Petersburg
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33702
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33702
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
351-3021
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
825569220 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2433 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2433 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
0 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
6200000 usd
CY2023Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
6200000 usd
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
28247 usd
CY2023Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
28247 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21165 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20719 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
483 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
929 usd
CY2023Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2023Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6239095 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6239541 usd
CY2023Q4 us-gaap Assets
Assets
6241528 usd
CY2023Q2 us-gaap Assets
Assets
6239541 usd
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2023Q2 us-gaap Bank Overdrafts
BankOverdrafts
46 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
69997 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
50664 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
743680 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
578017 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1265917 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1145917 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
63412 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
66794 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1478788 usd
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1465138 usd
CY2023Q4 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2088047 usd
CY2023Q2 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2090772 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
370301 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1035998 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6016730 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6366552 usd
CY2023Q4 us-gaap Liabilities
Liabilities
6016730 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6366552 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
756612000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
756612000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1154389824 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1154389824 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
115440 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
75663 usd
CY2023Q4 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2023Q2 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14579962 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14486896 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14479064 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14698030 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
224798 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-127011 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6241528 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6239541 usd
CY2023Q4 us-gaap Revenues
Revenues
0 usd
CY2022Q4 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q4 us-gaap Salaries And Wages
SalariesAndWages
60000 usd
CY2022Q4 us-gaap Salaries And Wages
SalariesAndWages
60000 usd
us-gaap Salaries And Wages
SalariesAndWages
120000 usd
us-gaap Salaries And Wages
SalariesAndWages
120000 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
45917 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
12992 usd
us-gaap Professional Fees
ProfessionalFees
62893 usd
us-gaap Professional Fees
ProfessionalFees
51113 usd
CY2023Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
60848 usd
CY2022Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
10696 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
61415 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
12001 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
166765 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
83688 usd
us-gaap Operating Expenses
OperatingExpenses
244308 usd
us-gaap Operating Expenses
OperatingExpenses
183114 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-166765 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-83688 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-244308 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-183114 usd
CY2023Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
167975 usd
CY2022Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1809922 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
711198 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1851116 usd
CY2023Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
24757 usd
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14878 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
48882 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
27493 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
135326 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
92535 usd
us-gaap Interest Expense
InterestExpense
247924 usd
us-gaap Interest Expense
InterestExpense
145743 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
32649 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1717387 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
463274 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1705373 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-134116 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1633699 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
218966 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1522259 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-134116 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1633699 usd
us-gaap Net Income Loss
NetIncomeLoss
218966 usd
us-gaap Net Income Loss
NetIncomeLoss
1522259 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
427583795 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
427583795 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
292900441 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
292900441 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
807957041 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
807957041 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301040848 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
301040848 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-127011 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
353082 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
226071 usd
CY2023Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
77111 usd
CY2023Q4 TMGI Common Stock Issued For Standby Equity Agreement
CommonStockIssuedForStandbyEquityAgreement
55731 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-134116 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
224798 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5654677 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-111440 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5766117 usd
CY2022Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
147507 usd
CY2022Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4200000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1633699 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
215089 usd
us-gaap Net Income Loss
NetIncomeLoss
218966 usd
us-gaap Net Income Loss
NetIncomeLoss
1522259 usd
us-gaap Depreciation
Depreciation
446 usd
us-gaap Depreciation
Depreciation
778 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
711198 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1851116 usd
TMGI Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
48882 usd
TMGI Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
27493 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19333 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
30914 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
197043 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
111316 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
120000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
110700 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-106528 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47657 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
-0 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
9247 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9247 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-46 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
TMGI Proceeds From Standby Equity Agreement
ProceedsFromStandbyEquityAgreement
55732 usd
TMGI Proceeds From Standby Equity Agreement
ProceedsFromStandbyEquityAgreement
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
56000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
69435 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2725 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
12100 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
108961 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
57335 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2433 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
431 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
353 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2433 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
784 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
45501 usd
TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
0 usd
TMGI Issuance Of Stock And Promissory Note For Investment In Acquisition
IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition
0 usd
TMGI Issuance Of Stock And Promissory Note For Investment In Acquisition
IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition
6200000 usd
TMGI Conversion Of Debt And Accrued Interest Into Common Stock
ConversionOfDebtAndAccruedInterestIntoCommonStock
77111 usd
TMGI Conversion Of Debt And Accrued Interest Into Common Stock
ConversionOfDebtAndAccruedInterestIntoCommonStock
147507 usd
CY2023Q4 TMGI Working Capital
WorkingCapital
6014297 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14479064 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
21648 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
21648 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21165 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20719 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
483 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
929 usd
CY2023Q4 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
us-gaap Depreciation
Depreciation
446 usd
us-gaap Depreciation
Depreciation
778 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1265917 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1145917 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1145917 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
120000 usd
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
240000 usd
TMGI Payments To Consultants
PaymentsToConsultants
0 usd
CY2023 TMGI Payments To Consultants
PaymentsToConsultants
-20300 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1265917 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1145917 usd
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1478788 usd
CY2023Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1465138 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1478788 usd
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1465138 usd
CY2023Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
0 usd
CY2023Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
0 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1542200 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1531932 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-63412 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-66794 usd
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1478788 usd
CY2023Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1465138 usd
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
279334689 shares
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
77111 usd
CY2023Q4 TMGI Notes Payable Related Parties
NotesPayableRelatedParties
2088047 usd
CY2023Q2 TMGI Notes Payable Related Parties
NotesPayableRelatedParties
2090772 usd
CY2023Q4 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2088047 usd
CY2023Q2 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2090772 usd
CY2023Q4 TMGI Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
0 usd
CY2023Q2 TMGI Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
0 usd
CY2023Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
613785 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
370301 usd
CY2023Q2 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
603517 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1035998 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
370301 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1035998 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,000 reverse split

Files In Submission

Name View Source Status
0001683168-24-000369-index-headers.html Edgar Link pending
0001683168-24-000369-index.html Edgar Link pending
0001683168-24-000369.txt Edgar Link pending
0001683168-24-000369-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
marquie_ex3101.htm Edgar Link pending
marquie_ex3201.htm Edgar Link pending
marquie_i10q-113023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
marquie_i10q-113023_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmgi-20231130.xsd Edgar Link pending
tmgi-20231130_cal.xml Edgar Link unprocessable
tmgi-20231130_lab.xml Edgar Link unprocessable
tmgi-20231130_pre.xml Edgar Link unprocessable
tmgi-20231130_def.xml Edgar Link unprocessable